This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Diabetes, Metabolic Syndrome And Cardiovascular Disease

5.1.10 Comparisons of the Anti-Diabetes Drugs 88

5.2 Drivers and Trends 89

5.2.1 Market Share of Anti-Diabetic Drugs 89

5.2.2 Forecasts for Anti-Diabetic Drugs 90

5.2.3 Sales Forecast for the Global Diabetes Market 91

5.3 The Future 92

5.3.1 Practice Patterns 92

5.3.2 New Products in Pipeline 92

5.3.2.1 Novel GLP-1 Agonists and Analogs 93

5.3.2.2 Novel DPP-IV Inhibitors 94

5.3.2.3 Sodium Glucose Cotransporter 2 (SGLT-2) 95

5.3.2.4 Emerging Non-Insulin Anti-Diabetes Targets and Drugs in the Pipeline 96

5.3.2.5 Novel Approaches to Finding New Drug Targets 99

5.4 Anti-Diabetic Drug Patent Expiry 100

5.5 Regulatory Issues 100

6. Insulin 1016.1 Insulin Markets 1016.1.1 Major Players and Market Share 1026.1.2 Patent Expirations 1046.1.3 Innovation Strategies 1046.2 Insulin Therapeutics 1056.2.1 Recommendations for Insulin Initiation and Administration 1056.2.2 Short-Acting Insulin 1086.2.3 Rapid-Acting Insulin 1086.2.4 Intermediate-Acting Insulin 1106.2.5 Long-Acting Insulin 1106.2.6 Long-Acting Insulins in Development 1116.2.7 Insulin Mixtures 1126.3 Pipeline Insulin 1126.4 Non-Invasive Insulin Delivery 1136.4.1 Inhaled Insulin 1146.4.1.1 A Chronicle of Inhaled Insulins 1156.4.2 Oral Insulin 1176.4.3 Transdermal Insulin 1206.5 Barriers for Non-Injected Insulin 1226.6 Patient Potential for Non-Injected Insulin 1226.7 Insulin Delivery Devices 1226.7.1 Insulin Pens 1236.7.2 Injections Aids 1286.7.2.1 Automatic Injectors 1296.7.2.2 Syringe Magnifiers 1296.7.2.3 Injection Ports 1306.7.3 Insulin Jet Injectors 1306.7.4 Insulin Pumps 1316.7.4.1 External Insulin Pumps 1326.7.4.2 Insulin Infusion Sets 1366.7.4.3 Insulin Patch Pumps in Development or Only Available Outside the U.S. 1376.7.4.4 Implantable Insulin Pumps 1396.7.4.5 Insulin Pump Market Share 1416.7.4.6 Drivers of Demand for Pumps 1426.8 Market Forecasts for Insulin Administration Technologies 142

7. Emerging Anti-Diabetes Technologies and Products 143

7.1 Projections for the Anti-Diabetes Drug Market 143

7.2 Artificial Pancreas 146

7.3 Insulin-Producing Cells 147

7.3.1 Cell Therapy Companies for Diabetes 148

7.4 Pancreatic Transplantation 149

7.4.1 Candidates for Pancreatic Transplantation 150

7.4.1.1 Pancreatic Organ Transplantation 151

7.4.1.2 Allo-Islet Transplantation 151

7.4.1.3 Implantation of Genetically Engineered b-Cells or Embryonic Stem Cells 151

3 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs